Eloxx Pharmaceuticals, Inc.
ELOX
$16.57
$0.402.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.50M | -3.75M | -1.89M | -6.23M | -6.32M |
| Total Depreciation and Amortization | -- | -- | -- | 186.00K | 178.00K |
| Total Amortization of Deferred Charges | 8.00K | 7.00K | 0.00 | 120.00K | 144.00K |
| Total Other Non-Cash Items | 157.00K | -10.00K | 128.00K | 1.02M | 606.00K |
| Change in Net Operating Assets | -452.00K | -1.70M | 10.00K | -1.91M | -270.00K |
| Cash from Operations | -4.79M | -5.45M | -1.75M | -6.81M | -5.66M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 11.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 11.00K | 0.00 |
| Total Debt Issued | -- | -- | 1.88M | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -7.50M | -- |
| Issuance of Common Stock | 60.30M | 40.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 91.00K | 6.99M | -- | -- | 312.00K |
| Cash from Financing | 60.39M | 7.03M | 1.88M | -7.50M | 312.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.60M | 1.58M | 122.00K | -14.30M | -5.35M |